Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences Feb 25, 2026 04:05PM
Terns Pharmaceuticals closes $747.5 million stock offering Dec 11, 2025 04:05PM
Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Dec 11, 2025 04:05PM
Terns Pharmaceuticals prices $650 million public offering at $40 per share Dec 9, 2025 11:30PM
Terns Announces Pricing of Upsized $650 Million Public Offering Dec 9, 2025 11:30PM


Dec 9, 2025 06:13AM Terns Pharmaceuticals announces $400 million public offering
Dec 9, 2025 06:12AM Terns Announces Proposed Public Offering
Feb 25, 2025 08:06AM Terns Pharmaceuticals (TERN) Provides Program Updates
Feb 25, 2025 08:05AM Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference
Sep 12, 2024 07:00PM Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Sep 11, 2024 06:18AM Terns Pharmaceuticals Inc. (TERN) Prices Upsized 11.92M Share Offering at $10.50/sh
Sep 10, 2024 10:50PM Terns Announces Pricing of Upsized $150.15 Million Public Offering
Sep 9, 2024 04:01PM Terns Pharmaceuticals Inc. (TERN) Announces Proposed $125M Share Offering
Sep 9, 2024 04:01PM Terns Announces Proposed Public Offering
Sep 6, 2024 09:18AM TD Cowen Reiterates Buy Rating on Terns Pharmaceuticals (TERN)
Feb 27, 2024 04:05PM Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences
May 24, 2023 04:05PM Terns Pharmaceuticals to Present at Upcoming Investor Conferences
Mar 2, 2023 04:05PM Terns Pharmaceuticals Provides Program Updates and Announces Participation at Upcoming March Investor Conferences
Mar 2, 2023 04:05PM Terns Pharmaceuticals Provides Program Updates and Announces Participation at Upcoming March Investor Conferences
Dec 23, 2022 04:05PM Terns Announces Closing of Public Offering of Shares of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Dec 23, 2022 04:05PM Terns Announces Closing of Public Offering of Shares of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Dec 21, 2022 05:57AM Terns Pharmaceuticals (TERN) Prices 10.35M Share Offering at $7.25/sh
Dec 20, 2022 07:39PM Terns Announces Pricing of $75 Million Public Offering
Dec 20, 2022 07:39PM Terns Announces Pricing of $75 Million Public Offering
Dec 19, 2022 04:31PM Terns Pharmaceuticals Inc. (TERN) Launches $75M Public Offering
Dec 19, 2022 04:31PM Terns Announces Proposed Public Offering
Dec 19, 2022 04:31PM Terns Announces Proposed Public Offering
Aug 12, 2022 08:00AM Terns Pharmaceuticals Inc. (TERN) Announces $65M Stock and Warrant Offering at $2.42/sh
Aug 12, 2022 08:00AM Terns Announces $65 Million Oversubscribed Offering
Aug 12, 2022 08:00AM Terns Announces $65 Million Oversubscribed Offering
Mar 22, 2022 12:48PM Cowen Reiterates Outperform Rating on Terns Pharmaceuticals (TERN), Believes VAP-1 is Not Well Understood and Could be Underappreciated
Feb 28, 2022 04:05PM Terns Pharmaceuticals to Participate in the Cowen 42nd Annual Healthcare Conference
Feb 28, 2022 04:05PM Terns Pharmaceuticals to Participate in the Cowen 42nd Annual Healthcare Conference
Mar 2, 2021 06:17AM UPDATE: Cowen Starts Terns Pharmaceuticals (TERN) at Outperform
Feb 23, 2021 04:35PM Terns to Present at the Cowen 41st Annual Health Care Conference
Feb 10, 2021 07:05AM Terns Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
Feb 5, 2021 12:53PM Terns Pharmaceuticals (TERN) IPO Opens Modestly Lower
Feb 5, 2021 06:21AM Terns Pharmaceuticals Inc. (TERN) Prices 7.5M Share Upsized IPO at $17/Sh
Feb 4, 2021 06:53PM Terns Pharmaceuticals, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock